Market report
Dermatological drug tenders in Czechia — market report, August 2026
Dermatological drug tenders in Czechia in August 2026: 6,719 tenders published (-2% month on month, +12% year on year), estimated at €1,627,048 in total, and 6,737 contracts awarded (0% month on month, +12% year on year), worth €27,858,646 (awarded value). Buyers with the most tenders: Krajská nemocnice T. Bati, a. s. (2,252), Krajská zdravotní, a.s. (774) and Fakultní nemocnice Bulovka (387); most contracts won: ROCHE s.r.o. (166), Phoenix - Plzen (131) and Takeda Pharmaceuticals Czech Republic s.r.o. (123). On average 1.0 bids per contract; 100% of contracts had a single bid. Report made on 27 October 2026.
- Tenders published
- 6,719
- Contracts awarded
- 6,737
- Contract value awarded
- €27,858,646
- Bids per contract
- 1.0
The highlighted bar is August 2026. Hover a bar for its figure; the table below has every value.
| Figure | August 2026 | July 2026 | Change | August 2025 | Change |
|---|---|---|---|---|---|
| Tenders published | 6,719 | 6,858 | -2% | 5,988 | +12% |
| Estimated value | €1,627,048 | €63,459 | +2,464% | €97,682 | +1,566% |
| Buyers | 28 | 28 | 0% | 30 | -7% |
| Contracts awarded | 6,737 | 6,764 | 0% | 6,004 | +12% |
| Contract value (awarded) | €27,858,646 | €31,070,137 | -10% | €4,347,195 | +541% |
| Winners | 273 | 304 | -10% | 264 | +3% |
| Bids per contract | 1.0 | 1.3 | — | 1.8 | — |
| Single-bid contracts | 100% | 92% | — | 40% | — |
Buyers with the most tenders
Companies with the most contracts
| # | Winners | Contracts |
|---|---|---|
| 1 | ROCHE s.r.o. | 166 |
| 2 | Phoenix - Plzen | 131 |
| 3 | Takeda Pharmaceuticals Czech Republic s.r.o. | 123 |
| 4 | ViaPharma s.r.o. | 114 |
| 5 | Janssen-Cilag s.r.o. | 114 |
| 6 | AbbVie s.r.o. | 102 |
| 7 | BAYER s.r.o. | 80 |
| 8 | Amgen s.r.o. | 73 |
| 9 | ELI LILLY ČR, s.r.o. | 73 |
| 10 | FAGRON a.s. | 70 |
Where the tenders were
Procedures
The report's aggregates: the figures, the comparisons and the top lists by name and count.
All reports: Dermatological and musculoskeletal drugs
Questions and answers
- How many dermatological drug tenders were published in Czechia in August 2026?
- 6,719 (by 28 buyers); for comparison, July 2026: 6,858, August 2025: 5,988.
- Who won the most dermatological drug tenders in Czechia in August 2026?
- By number of contracts: ROCHE s.r.o. (166), Phoenix - Plzen (131), Takeda Pharmaceuticals Czech Republic s.r.o. (123), ViaPharma s.r.o. (114) and Janssen-Cilag s.r.o. (114); 273 companies won contracts in all.
- Which buyers published the most dermatological drug tenders in August 2026?
- Krajská nemocnice T. Bati, a. s. (2,252), Krajská zdravotní, a.s. (774), Fakultní nemocnice Bulovka (387), Nemocnice České Budějovice, a.s. (339) and Fakultní nemocnice Brno (272).
- How competitive were dermatological drug tenders in Czechia in August 2026?
- On average 1.0 bids per contract (22 contracts with a known number of bids); 100% of contracts had a single bid.
- What were the contracts worth in August 2026?
- €27,858,646 (awarded value, 6,737 contracts); median about €770,000.
How the report is made
Tenders published: the tenders of the sector or topic whose first notice is dated in the month (a tender counts in its sector and in up to three topics). Contracts awarded: the awards dated in the month, whenever their tender was published. Values in EUR, by value kind (never added together); medians are approximate (±3 %). Comparisons: with the reports of the previous month and of the same month a year earlier, each made the same way. The report was made on 27 October 2026 from the data of that day and is not changed afterwards; sources publish late, so later data for the month are not in it.